Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 26.9 % |
Candida albicans | fructose-bisphosphate aldolase | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 358 aa | 22.6 % |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | Putative fructose-1,6-bisphosphate aldolase | 323 aa | 361 aa | 25.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.1126 | 1 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase Nek1 | 0.1097 | 0.9732 | 1 |
Trypanosoma brucei | NIMA-related protein kinase | 0.1126 | 1 | 0.5 |
Giardia lamblia | Kinase, NEK | 0.1126 | 1 | 1 |
Echinococcus granulosus | serine:threonine protein kinase Nek1 | 0.1097 | 0.9732 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0 | 0.5 |
Trypanosoma brucei | Serine/threonine-protein kinase NEK11, putative | 0.1126 | 1 | 0.5 |
Leishmania major | protein kinase, putative,serine/threonine-protein kinase Nek1, putative | 0.1126 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0172 | 0.1094 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.1126 | 1 | 1 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0172 | 0.1094 | 0.5 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK16, putative | 0.1126 | 1 | 1 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK11, putative | 0.1126 | 1 | 1 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0353 | 0.278 | 0.5 |
Trypanosoma cruzi | NIMA-related kinase, putative | 0.1126 | 1 | 1 |
Plasmodium falciparum | NIMA related kinase 2 | 0.1126 | 1 | 0.5 |
Toxoplasma gondii | NEK kinase | 0.1126 | 1 | 0.5 |
Plasmodium falciparum | NIMA related kinase 4 | 0.1126 | 1 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0 | 0.5 |
Leishmania major | protein kinase, putative | 0.1126 | 1 | 0.5 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK11, putative | 0.1126 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.1126 | 1 | 1 |
Plasmodium vivax | serine/threonine-protein kinase Nek1, putative | 0.1126 | 1 | 0.5 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0172 | 0.1094 | 0.5 |
Leishmania major | serine/threonine-protein kinase, putative | 0.1126 | 1 | 0.5 |
Trichomonas vaginalis | STE family protein kinase | 0.1126 | 1 | 1 |
Trypanosoma brucei | Serine/threonine-protein kinase NEK16, putative | 0.1126 | 1 | 0.5 |
Toxoplasma gondii | NEK kinase | 0.1126 | 1 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1126 | 1 | 1 |
Plasmodium vivax | serine/threonine-protein kinase NEK4, putative | 0.1126 | 1 | 0.5 |
Toxoplasma gondii | NEK kinase | 0.1126 | 1 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.1126 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.